Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Mil Med ; 178(12): e1384-7, 2013 Dec.
Article in English | MEDLINE | ID: mdl-24306025

ABSTRACT

Antitumor necrosis factor alpha agents are known to increase the risk for severe and atypical infections. Numerous atypical organisms have been reported previously, however, there is a paucity of reports of Salmonella as a complication of these therapies. We report a case of a 69-year-old female who developed Salmonella septic arthritis of the pubic symphysis while taking etanercept that resolved with cessation of etanercept and antibiotic treatment and we review the literature regarding this complication. Awareness of susceptibility to Gram-negative intracellular organisms and reactivation of dormant infections due to the mechanism of action of antitumor necrosis factor alpha medications is vital.


Subject(s)
Arthritis, Infectious/etiology , Immunoglobulin G/adverse effects , Immunosuppressive Agents/adverse effects , Pubic Symphysis , Salmonella Infections/etiology , Aged , Arthritis, Infectious/microbiology , Arthritis, Rheumatoid/drug therapy , Etanercept , Female , Humans , Receptors, Tumor Necrosis Factor , Salmonella Infections/microbiology
2.
Mil Med ; 178(8): e967-9, 2013 Aug.
Article in English | MEDLINE | ID: mdl-23929065

ABSTRACT

The median arcuate ligament syndrome is an uncommon condition characterized by the triad of postprandial abdominal pain, unintentional weight loss, and an epigastric bruit. This condition is diagnostically challenging and patients often undergo extensive laboratory, radiographic, and invasive evaluations before it is identified. Physicians should consider this syndrome in the differential diagnoses of chronic abdominal pain and mesenteric vasculitis. Once diagnosed, treatment is generally surgical with known predictors of favorable and unfavorable outcomes. Surgical candidates should be selected carefully. We describe the cases of two young active duty patients diagnosed with median arcuate ligament syndrome after suffering from chronic abdominal pain. Both were referred to our rheumatology department to evaluate for mesenteric vasculitis. Each had a different therapeutic outcome.


Subject(s)
Abdominal Pain/etiology , Arterial Occlusive Diseases/diagnosis , Arteritis/diagnosis , Celiac Artery , Mesenteric Arteries , Weight Loss , Adult , Arterial Occlusive Diseases/surgery , Chronic Pain/etiology , Diagnosis, Differential , Female , Humans , Ligaments , Male , Military Personnel , Postprandial Period , Syndrome , Young Adult
3.
J Clin Rheumatol ; 14(2): 82-6, 2008 Apr.
Article in English | MEDLINE | ID: mdl-18391676

ABSTRACT

BACKGROUND AND OBJECTIVES: Greater trochanteric (GT) bursitis is a common cause of hip pain. Previously, the etiology of the trochanteric pain syndrome was thought to be caused by inflammation of the subgluteus maximus bursa (i.e., bursitis). Recently, MRI and ultrasound studies have brought into serious doubt the idea that bursitis is the etiology for trochanteric pain. To our knowledge, no histologic study of GT bursitis has been reported to date. The purpose of this study is to evaluate the histopathology of patients with and without the clinical syndrome of GT bursitis to assess for the presence of bursal inflammation. DESIGN AND METHODS: This is a prospective, case-controlled, blinded study of the histopathologic features of controls and patients with GT bursitis. We recruited patients who required total hip arthroplasty (THA) for rheumatoid or osteoarthritis. Inclusion criteria for the study consisted of the following: needing THA as standard of care; THA secondary to OA or RA; age greater than 18; and minimal risk for surgery by the American Heart Association Criteria. We excluded anyone who received a GT bursa injection 9 months before surgery. Eligible participants were then stratified as cases or controls using the 1985 clinical criteria for GT bursitis. The harvesting of the bursa required no modification of the surgical procedure. The specimens were then examined by 2 independent pathologists who were blinded as to the patients' clinical status. RESULTS: Six bursal specimens were evaluated by 2 blinded surgical pathologists revealing primarily fibroadipose tissue with no signs of acute or chronic inflammation. There were 3 bursas in the control group and 2 specimens with clinical GT bursitis. No significant differences were found between the specimens of the 2 groups. CONCLUSIONS: The results of this small prospective observational histologic study, along with recent MRI and ultrasound studies on the topic, strongly suggest that there is no etiologic role of bursal inflammation in the trochanteric pain syndrome.


Subject(s)
Arthroplasty, Replacement, Hip , Bursa, Synovial/pathology , Bursitis/pathology , Femur/pathology , Hip Joint/pathology , Aged , Bursitis/immunology , Case-Control Studies , Female , Femur/immunology , Humans , Inflammation/pathology , Male , Middle Aged
4.
Arthritis Rheum ; 49(2): 200-8, 2003 Apr 15.
Article in English | MEDLINE | ID: mdl-12687511

ABSTRACT

OBJECTIVE: To assess the extent of ethnic variation in the clinical expression of rheumatoid arthritis (RA) and the role of HLA-DRB1 alleles in this variation. METHODS: We assessed consecutive RA patients for joint findings, subcutaneous nodules, laboratory and radiographic findings, and treatment. We typed HLA-DRB1 alleles to identify those that contain the shared epitope (SE). We adjusted ethnic comparisons for age and sex, and tested for ethnic heterogeneity in the effect of the SE. RESULTS: We studied 777 RA patients, 498 of whom were women (64%), 432 were Hispanic (56%), 272 were non-Hispanic white (NHW; 35%), 53 were African American (AA; 7%), and 20 were Asian (3%). Compared with NHW, Hispanics had significantly more tender joints (17 versus 11), more swollen joints (8 versus 7), more frequent rheumatoid factor (RF) positivity (93% versus 84%), higher erythrocyte sedimentation rate (ESR; 45 versus 36 mm/hr), and a lower number of lifetime disease-modifying antirheumatic drugs (1.9 versus 2.5). AA were older at onset (46 versus 44 years), had less frequent subcutaneous nodules (18% versus 28%), and higher ESR (42 versus 36 mm/hour) than did NHW. Hispanics and AA were more likely than NHW to be null for the SE (odds ratio [OR] = 4.59 for AA; and OR = 1.61 for Hispanics), and less likely to have 2 SE-carrying alleles (OR = 0.59 for Hispanics and OR = 0.25 for AA). The number of SE copies was associated with subcutaneous nodules, ESR, RF, and radiographic changes. Ethnic heterogeneity in the effect of the SE was modest. CONCLUSIONS: There is ethnic variation in the clinical expression of RA and in both the frequency and types of SE-carrying HLA-DRB1 alleles. Some ethnic variation in clinical findings is associated with differences in SE frequency. However, we found that the effect of the SE on the clinical features of RA varies little between ethnic groups.


Subject(s)
Arthritis, Rheumatoid , HLA-DR Antigens/genetics , Aged , Alleles , Arthritis, Rheumatoid/diagnosis , Arthritis, Rheumatoid/ethnology , Arthritis, Rheumatoid/genetics , Asian People/genetics , Black People/genetics , Epitopes/genetics , Female , Gene Dosage , Genetic Heterogeneity , Genetic Predisposition to Disease/epidemiology , HLA-DRB1 Chains , Humans , Male , Middle Aged , White People/genetics
5.
Arthritis Rheum ; 46(6): 1480-8, 2002 Jun.
Article in English | MEDLINE | ID: mdl-12115177

ABSTRACT

OBJECTIVE: To test the hypothesis that the influence of the HLA-DRB1 shared epitope (SE) on the clinical manifestations of rheumatoid arthritis (RA) differs between men and women. METHODS: We assessed 777 consecutive RA patients for age at disease onset, articular manifestations, subcutaneous nodules, laboratory and radiographic findings, and treatment received. We typed HLA-DRB1 alleles by polymerase chain reaction-sequence-specific primer amplification and categorized the number of SE-containing alleles. We used regression models to adjust comparisons between the sexes for age and clustering by recruitment center, and included SE x sex interaction terms to look for heterogeneity between men and women in the effect of the SE. RESULTS: Among the 777 RA patients, 548 (71%) were women. Men and women differed significantly in the adjusted frequency of SE positivity (women 71.4% versus men 78.4%; P < or = 0.001). The SE was associated with a younger age at symptom onset and RA diagnosis among men, but not among women. The SE likewise had a significant adverse effect on joint tenderness, swelling, and deformity among men only. The SE was associated with a higher erythrocyte sedimentation rate in women and more frequent positivity for rheumatoid factor among both men and women. CONCLUSION: There is heterogeneity between men and women in the effect of the SE on RA susceptibility and clinical expression. Further research is needed to understand the mechanism of this heterogeneity.


Subject(s)
Arthritis, Rheumatoid/epidemiology , Arthritis, Rheumatoid/genetics , Epitopes/genetics , Genetic Heterogeneity , HLA-DR Antigens/genetics , Aged , Female , Genetic Predisposition to Disease , HLA-DRB1 Chains , Humans , Male , Middle Aged , Risk Factors , Sex Distribution
SELECTION OF CITATIONS
SEARCH DETAIL
...